The global Enteric Softgel Capsules market size is predicted to grow from US$ 1741 million in 2025 to US$ 2015 million in 2031; it is expected to grow at a CAGR of 2.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Softgel capsules is an oral dosage form for medicine that contains a pharmaceutical liquid enclosed by gelatin-based shell. Enteric softgel capsules are coated with polymers such as cellulose, vinyl, and acrylic derivatives.

These formulation of drugs have gained popularity as they exhibit resistance to gastric fluids and easily solubilizes in intestinal tract. The enteric coating also maintains the mechanical, adhesive, and disintegration properties of softgel capsules.

Infinity Market Research newest research report, the Enteric Softgel Capsules Industry Forecast looks at past sales and reviews total world Enteric Softgel Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Enteric Softgel Capsules sales for 2025 through 2031. With Enteric Softgel Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enteric Softgel Capsules industry.

This Insight Report provides a comprehensive analysis of the global Enteric Softgel Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enteric Softgel Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Enteric Softgel Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enteric Softgel Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enteric Softgel Capsules.

This report presents a comprehensive overview, market shares, and growth opportunities of Enteric Softgel Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Gelatin Type
    Vegetable Type

Segmentation by Application:

    Supermarket & Hypermarket
    Pharmacy & Drug Store
    Online Retail

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Catalent
    Sirio Pharma
    Aenova
    ProCaps
    InovoBiologic
    Alpha
    Dart Neuroscience
    BASF
    Lonza
    NutraNorth

Key Questions Addressed in this Report

What is the 10-year outlook for the global Enteric Softgel Capsules market?
What factors are driving Enteric Softgel Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enteric Softgel Capsules market opportunities vary by end market size?
How does Enteric Softgel Capsules break out by Type, by Application?